Recent News

• 08.20.2025 - Iterum Therapeutics launches ORLYNVAH™, the first and only oral penem antibiotic in the U.S.
• 08.20.2025 - Iterum Therapeutics launches ORLYNVAH™, the first and only oral penem antibiotic in the U.S.
• 08.05.2025 - Iterum Therapeutics Reports Second Quarter 2025 Financial Results
• 08.05.2025 - Iterum Therapeutics Reports Second Quarter 2025 Financial Results
• 07.29.2025 - Iterum Therapeutics to Report Second Quarter 2025 Financial Results on August 5, 2025
• 07.29.2025 - Iterum Therapeutics to Report Second Quarter 2025 Financial Results on August 5, 2025
• 07.02.2025 - Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 07.02.2025 - Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Recent Filings

• 08.20.2025 - 8-K Current report
• 08.20.2025 - EX-99.1 EX-99.1
• 08.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.05.2025 - EX-99.1 EX-99.1
• 08.05.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.05.2025 - 8-K Current report
• 08.04.2025 - 8-K Current report
• 07.29.2025 - DEF 14A Other definitive proxy statements
• 07.18.2025 - 8-K Current report
• 07.18.2025 - PRE 14A Other preliminary proxy statements